Enteropathogenic Escherichia coli (EPEC) is a leading cause of severe infantile diarrhea in developing countries. Previous research has focused on the diversity of the EPEC virulence plasmid, whereas less is known regarding the genetic content and distribution of antibiotic resistance plasmids carried by EPEC. A previous study demonstrated that in addition to the virulence plasmid, reference EPEC strain B171 harbors a second, larger plasmid that confers antibiotic resistance. To further understand the genetic diversity and dissemination of antibiotic resistance plasmids among EPEC strains, we describe the complete sequence of an antibiotic resistance plasmid from EPEC strain B171. The resistance plasmid, pB171_90, has a completed sequence length of 90,229 bp, a GC content of 54.55%, and carries protein-encoding genes involved in conjugative transfer, resistance to tetracycline (tetA), sulfonamides (sulI), and mercury, as well as several virulence-associated genes, including the transcriptional regulator hha and the putative calcium sequestration inhibitor (csi). In silico detection of the pB171_90 genes among 4,798 publicly available E. coli genome assemblies indicates that the unique genes of pB171_90 (csi and traI) are primarily restricted to genomes identified as EPEC or enterotoxigenic E. coli. However, conserved regions of the pB171_90 plasmid containing genes involved in replication, stability, and antibiotic resistance were identified among diverse E. coli pathotypes. Interestingly, pB171_90 also exhibited significant similarity with a sequenced plasmid from Shigella dysenteriae type I. Our findings demonstrate the mosaic nature of EPEC antibiotic resistance plasmids and highlight the need for additional sequence-based characterization of antibiotic resistance plasmids harbored by pathogenic E. coli.
KEYWORDS EPEC, Escherichia coli, mosaic, plasmidT here has been an alarming increase in the frequency of antibiotic resistance in bacterial pathogens. Multidrug-resistant Enterobacteriaceae are of particular concern and include some groups of disease-causing Escherichia coli (1-3). E. coli strains have been identified that are resistant to all routinely prescribed antibiotics, including colistin, which is a last resort treatment option for carbapenem-resistant Enterobacteriaceae (4-7). The most widely reported antibiotic-resistant E. coli strains are those belonging to multilocus sequence type (MLST) 131 (ST131), which are usually identified as extraintestinal pathogenic E. coli (ExPEC) and often exhibit resistance to fluoroquinolones, as well as extended-spectrum cephalosporins (1,8). E. coli can also serve as a reservoir of antibiotic resistance genes, including mph(A), which confers resistance to macrolides such as azithromycin (9). E. coli strains from healthy volunteers in different